Lung Cancer Trials Ask AI to find trials
CompletedPhase 4NCT03611881
Official study title

Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

Study summary

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedCounseling and Nicotine patch

Plus 1 other study approaches.

Who it may be forSmoking, Tobacco

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 28, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 4

Interventional

Where is it offered?6 U.S. locations

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 4
Sponsor
Massachusetts General Hospital
Interventions being studied
Behavioral: Counseling; Drug: Nicotine patch; Behavioral: Community Resource
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site
  • Speak English or Spanish.
  • Current smokers: smoked a cigarette, even a puff, in the last 30 days.
  • Medicare coverage requirement (age 50-80 years, 20+ pack/years).
  • Residing within the USA.
Reasons someone may not be able to joinExclusion criteria
  • Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.
  • Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.
  • No access to a telephone or cannot communicate by telephone.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Massachusetts General HospitalBoston, Massachusetts
  • Brigham & Women's HospitalBoston, Massachusetts
  • Brigham & Women's Faulkner HospitalBoston, Massachusetts
  • Newton-Wellesley HospitalNewton, Massachusetts
  • Martha's Vineyard HospitalOak Bluffs, Massachusetts
  • Salem HospitalSalem, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 28, 2024. Always confirm current availability with the study team.

View original record ↗